PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of moloncolLink to Publisher's site
 
Mol Oncol. 2017 September; 11(9): 1302–1303.
Published online 2017 September 1. doi:  10.1002/1878-0261.12118
PMCID: PMC5579339

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer

Volume 11, Issue 6, pages 640–654. First published: 12 May 2017

The authors of this article have supplied the following correction.

Figure 1E was mistakenly replaced by Fig. 1G of He et al. (2016) during the final assembly of the figures for review. The corrected figure is provided below. The authors apologize for the error.

Figure 1
FEN1 overexpression was associated with lung cancer. (A) FEN1 expression analysis based on TCGA dataset showed that FEN1 mRNA levels were higher in lung cancer tissue than in normal tissue (*P < 0.01 vs control group). (B) FEN ...

References

  • He L, Zhang Y, Sun H, Jiang F, Yang H, Wu H, Zhou T, Hu S, Sekhar Kathera C, Wang X et al (2016) Targeting DNA flap endonuclease 1 to impede breast cancer progression. EBioMedicine 14, 32–43. [PubMed]

Articles from Molecular Oncology are provided here courtesy of Wiley-Blackwell